BRIEF-Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry

Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS

0.00

June 16 (Reuters) - Intelligent Bio Solutions Inc INBS.O:

  • INTELLIGENT BIO SOLUTIONS INITIATES CLINICAL STUDY SUPPORTING FDA CLEARANCE AND PLANNED U.S. MARKET ENTRY

  • INTELLIGENT BIO SOLUTIONS - EXPECTS TO COMPLETE INTERFERENCE STUDY BY MID-JULY 2026 FOR FDA 510(K) SUBMISSION

Source text: ID:nGNXbjT8hX

Further company coverage: INBS.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.